Li Gong

This publication record appears to combine work from multiple researchers sharing the name Li Gong, spanning hepatocellular carcinoma treatment (especially radiotherapy combined with drug therapies), cancer diagnostics using imaging and molecular markers, and other unrelated topics like groundwater chemistry and traffic systems. The core clinical focus involves studying how radiotherapy, drug combinations, and nanomaterial-based delivery systems can improve outcomes for liver cancer and other cancers such as esophageal and glioma. Prospective students should note the topic diversity here likely reflects distinct authors rather than one unified research program.

Publication output was low and relatively steady (1-4 per year) from 2017-2023, then increased sharply to 9 papers each in 2024 and 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026